Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8240844 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 6 Pages |
Abstract
In this study, high tumor burden assessed by PET MTV is an independent poor prognostic feature in lung cancer, promising for stratifying patients in randomized trials and ultimately for selecting risk-adapted therapies. These results will need to be validated in larger cohorts with longer follow-up, and evaluated prospectively.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Percy M.D., Dilani K. B.S., Philip W. Ph.D., Andrew M.D., Wendy M.D., Peter G. Ph.D., Quynh-Thu M.D., Heather A. M.D., Jessica S. M.D, Edward E. Ph.D., Billy W. M.D., Ph.D.,